Custom Antibody Services Market By Service , By Type By Source By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

Description

Custom Antibody Services Market

The custom antibody services market was valued at $0.6 billion in 2023 and is projected to reach $1.4 billion by 2033, growing at a CAGR of 8.7% from 2024 to 2033.

Custom antibody services involve producing distinguished antibodies as per user requirements. The antibodies are specifically tailored for diagnostic, research, and therapeutic purposes. A key benefit of utilizing custom antibody services is the attainability of specificity in antibodies against antigens, resulting in improved & reliable experimental results. In addition, the flexibility of integrating different modifications into the antibodies attracts clients to benefit from the custom antibody services.

Increase in the popularity of personalized medicine for targeted therapies is rising the adoption of custom antibody services in the healthcare field. In addition, with surging expenditure in the pharmaceutical and biotech sectors for the strengthening of their R&D activities, the growth of the market is being driven considerably. The future of the custom antibody services market is anticipated to be redefined by recombinant technology and novel antibody trends. AI and ML algorithm are poised to assist in the designing of antibodies and develop next-generational antibodies such as single domain antibodies, bispecific antibodies, and antibody fragments.

However, the high cost of antibody production and extended development time hamper the growth of the custom antibody services market. In addition, the quality control measures and validation processes established for the approval of antibodies are highly rigorous and time-consuming. Efficient compliance with such standards delays the growth of the market. Contrarily, with rising investments on drug development and R&D, the custom antibody services market is anticipated to witness several lucrative growth opportunities. According to Statista, a global data and business intelligence platform, the U.S. spent an estimated amount of $603 billion on medicine in 2022. Furthermore, pharma companies in the U.S. spend approximately 21% of their revenue on R&D activities. Such expenditures indicate a promising future for the custom antibody services market.

Segment Review

The custom antibody services market is segmented into service, type, source, application, end user, and region. On the basis of service, the market is divided into antibody development, antibody production & purification, and antibody fragmentation & labeling. As per type, it is classified into monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and others. Depending on source, it is categorized into mice, rabbit, and others. According to application, it is divided into oncology, infectious diseases, neurology, immunology, cardiovascular diseases, and others. By end user, it is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of service, the antibody development segment dominated the market in 2023.

As per type, the monoclonal antibodies segment was the major shareholder of the market in 2023.

Depending on source, the rabbit segment held a high share in the market in 2023.

According to application, the infectious diseases segment accounted for a high share in the market in 2023.

By end user, the pharmaceutical & biotechnology companies segment acquired a high stake in the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The major players of the global custom antibody services market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., Sino Biological, Inc., Bio-Rad Laboratories, Inc, Kaneka Eurogentec S.A., YenZym Antibodies, LLC., OriGene Technologies, Inc., Laboratory Corporation of America Holdings., and GenScript. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Service

Antibody Development
Antibody Production and Purification
Antibody Fragmentation and Labeling

By Type

Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Antibodies
Others

By Source

Mice
Rabbit
Others

By Application

Oncology
Infectious Diseases
Neurology
Immunology
Cardiovascular Diseases
Others

By End User

Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

Thermo Fisher Scientific Inc.
Merck KGaA
Agilent Technologies, Inc.
Sino Biological, Inc.
Bio-Rad Laboratories, Inc
Kaneka Eurogentec S.A.
YenZym Antibodies, LLC.
OriGene Technologies, Inc.
Laboratory Corporation of America Holdings.
GenScript

Product Code: A324397

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE

4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Service
4.2. Antibody Development
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
4.3. Antibody Production And Purification
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
4.4. Antibody Fragmentation And Labeling
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country

CHAPTER 5: CUSTOM ANTIBODY SERVICES MARKET, BY TYPE

5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Type
5.2. Monoclonal Antibodies
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
5.3. Polyclonal Antibodies
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
5.4. Recombinant Antibodies
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
5.5. Others
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country

CHAPTER 6: CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE

6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Source
6.2. Mice
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
6.3. Rabbit
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
6.4. Others
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country

CHAPTER 7: CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION

7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Application
7.2. Oncology
- 7.2.1. Key Market Trends, Growth Factors and Opportunities
- 7.2.2. Market Size and Forecast, By Region
- 7.2.3. Market Share Analysis, By Country
7.3. Infectious Diseases
- 7.3.1. Key Market Trends, Growth Factors and Opportunities
- 7.3.2. Market Size and Forecast, By Region
- 7.3.3. Market Share Analysis, By Country
7.4. Neurology
- 7.4.1. Key Market Trends, Growth Factors and Opportunities
- 7.4.2. Market Size and Forecast, By Region
- 7.4.3. Market Share Analysis, By Country
7.5. Immunology
- 7.5.1. Key Market Trends, Growth Factors and Opportunities
- 7.5.2. Market Size and Forecast, By Region
- 7.5.3. Market Share Analysis, By Country
7.6. Cardiovascular Diseases
- 7.6.1. Key Market Trends, Growth Factors and Opportunities
- 7.6.2. Market Size and Forecast, By Region
- 7.6.3. Market Share Analysis, By Country
7.7. Others
- 7.7.1. Key Market Trends, Growth Factors and Opportunities
- 7.7.2. Market Size and Forecast, By Region
- 7.7.3. Market Share Analysis, By Country

CHAPTER 8: CUSTOM ANTIBODY SERVICES MARKET, BY END USER

8.1. Market Overview
- 8.1.1 Market Size and Forecast, By End User
8.2. Pharmaceutical And Biotechnology Companies
- 8.2.1. Key Market Trends, Growth Factors and Opportunities
- 8.2.2. Market Size and Forecast, By Region
- 8.2.3. Market Share Analysis, By Country
8.3. Academic And Research Institutes
- 8.3.1. Key Market Trends, Growth Factors and Opportunities
- 8.3.2. Market Size and Forecast, By Region
- 8.3.3. Market Share Analysis, By Country
8.4. Others
- 8.4.1. Key Market Trends, Growth Factors and Opportunities
- 8.4.2. Market Size and Forecast, By Region
- 8.4.3. Market Share Analysis, By Country

CHAPTER 9: CUSTOM ANTIBODY SERVICES MARKET, BY REGION

9.1. Market Overview
- 9.1.1 Market Size and Forecast, By Region
9.2. North America
- 9.2.1. Key Market Trends and Opportunities
- 9.2.2. Market Size and Forecast, By Service
- 9.2.3. Market Size and Forecast, By Type
- 9.2.4. Market Size and Forecast, By Source
- 9.2.5. Market Size and Forecast, By Application
- 9.2.6. Market Size and Forecast, By End User
- 9.2.7. Market Size and Forecast, By Country
- 9.2.8. U.S. Custom Antibody Services Market
  - 9.2.8.1. Market Size and Forecast, By Service
  - 9.2.8.2. Market Size and Forecast, By Type
  - 9.2.8.3. Market Size and Forecast, By Source
  - 9.2.8.4. Market Size and Forecast, By Application
  - 9.2.8.5. Market Size and Forecast, By End User
- 9.2.9. Canada Custom Antibody Services Market
  - 9.2.9.1. Market Size and Forecast, By Service
  - 9.2.9.2. Market Size and Forecast, By Type
  - 9.2.9.3. Market Size and Forecast, By Source
  - 9.2.9.4. Market Size and Forecast, By Application
  - 9.2.9.5. Market Size and Forecast, By End User
- 9.2.10. Mexico Custom Antibody Services Market
  - 9.2.10.1. Market Size and Forecast, By Service
  - 9.2.10.2. Market Size and Forecast, By Type
  - 9.2.10.3. Market Size and Forecast, By Source
  - 9.2.10.4. Market Size and Forecast, By Application
  - 9.2.10.5. Market Size and Forecast, By End User
9.3. Europe
- 9.3.1. Key Market Trends and Opportunities
- 9.3.2. Market Size and Forecast, By Service
- 9.3.3. Market Size and Forecast, By Type
- 9.3.4. Market Size and Forecast, By Source
- 9.3.5. Market Size and Forecast, By Application
- 9.3.6. Market Size and Forecast, By End User
- 9.3.7. Market Size and Forecast, By Country
- 9.3.8. Germany Custom Antibody Services Market
  - 9.3.8.1. Market Size and Forecast, By Service
  - 9.3.8.2. Market Size and Forecast, By Type
  - 9.3.8.3. Market Size and Forecast, By Source
  - 9.3.8.4. Market Size and Forecast, By Application
  - 9.3.8.5. Market Size and Forecast, By End User
- 9.3.9. France Custom Antibody Services Market
  - 9.3.9.1. Market Size and Forecast, By Service
  - 9.3.9.2. Market Size and Forecast, By Type
  - 9.3.9.3. Market Size and Forecast, By Source
  - 9.3.9.4. Market Size and Forecast, By Application
  - 9.3.9.5. Market Size and Forecast, By End User
- 9.3.10. UK Custom Antibody Services Market
  - 9.3.10.1. Market Size and Forecast, By Service
  - 9.3.10.2. Market Size and Forecast, By Type
  - 9.3.10.3. Market Size and Forecast, By Source
  - 9.3.10.4. Market Size and Forecast, By Application
  - 9.3.10.5. Market Size and Forecast, By End User
- 9.3.11. Italy Custom Antibody Services Market
  - 9.3.11.1. Market Size and Forecast, By Service
  - 9.3.11.2. Market Size and Forecast, By Type
  - 9.3.11.3. Market Size and Forecast, By Source
  - 9.3.11.4. Market Size and Forecast, By Application
  - 9.3.11.5. Market Size and Forecast, By End User
- 9.3.12. Spain Custom Antibody Services Market
  - 9.3.12.1. Market Size and Forecast, By Service
  - 9.3.12.2. Market Size and Forecast, By Type
  - 9.3.12.3. Market Size and Forecast, By Source
  - 9.3.12.4. Market Size and Forecast, By Application
  - 9.3.12.5. Market Size and Forecast, By End User
- 9.3.13. Rest of Europe Custom Antibody Services Market
  - 9.3.13.1. Market Size and Forecast, By Service
  - 9.3.13.2. Market Size and Forecast, By Type
  - 9.3.13.3. Market Size and Forecast, By Source
  - 9.3.13.4. Market Size and Forecast, By Application
  - 9.3.13.5. Market Size and Forecast, By End User
9.4. Asia-Pacific
- 9.4.1. Key Market Trends and Opportunities
- 9.4.2. Market Size and Forecast, By Service
- 9.4.3. Market Size and Forecast, By Type
- 9.4.4. Market Size and Forecast, By Source
- 9.4.5. Market Size and Forecast, By Application
- 9.4.6. Market Size and Forecast, By End User
- 9.4.7. Market Size and Forecast, By Country
- 9.4.8. Japan Custom Antibody Services Market
  - 9.4.8.1. Market Size and Forecast, By Service
  - 9.4.8.2. Market Size and Forecast, By Type
  - 9.4.8.3. Market Size and Forecast, By Source
  - 9.4.8.4. Market Size and Forecast, By Application
  - 9.4.8.5. Market Size and Forecast, By End User
- 9.4.9. China Custom Antibody Services Market
  - 9.4.9.1. Market Size and Forecast, By Service
  - 9.4.9.2. Market Size and Forecast, By Type
  - 9.4.9.3. Market Size and Forecast, By Source
  - 9.4.9.4. Market Size and Forecast, By Application
  - 9.4.9.5. Market Size and Forecast, By End User
- 9.4.10. India Custom Antibody Services Market
  - 9.4.10.1. Market Size and Forecast, By Service
  - 9.4.10.2. Market Size and Forecast, By Type
  - 9.4.10.3. Market Size and Forecast, By Source
  - 9.4.10.4. Market Size and Forecast, By Application
  - 9.4.10.5. Market Size and Forecast, By End User
- 9.4.11. Australia Custom Antibody Services Market
  - 9.4.11.1. Market Size and Forecast, By Service
  - 9.4.11.2. Market Size and Forecast, By Type
  - 9.4.11.3. Market Size and Forecast, By Source
  - 9.4.11.4. Market Size and Forecast, By Application
  - 9.4.11.5. Market Size and Forecast, By End User
- 9.4.12. South Korea Custom Antibody Services Market
  - 9.4.12.1. Market Size and Forecast, By Service
  - 9.4.12.2. Market Size and Forecast, By Type
  - 9.4.12.3. Market Size and Forecast, By Source
  - 9.4.12.4. Market Size and Forecast, By Application
  - 9.4.12.5. Market Size and Forecast, By End User
- 9.4.13. Rest of Asia-Pacific Custom Antibody Services Market
  - 9.4.13.1. Market Size and Forecast, By Service
  - 9.4.13.2. Market Size and Forecast, By Type
  - 9.4.13.3. Market Size and Forecast, By Source
  - 9.4.13.4. Market Size and Forecast, By Application
  - 9.4.13.5. Market Size and Forecast, By End User
9.5. LAMEA
- 9.5.1. Key Market Trends and Opportunities
- 9.5.2. Market Size and Forecast, By Service
- 9.5.3. Market Size and Forecast, By Type
- 9.5.4. Market Size and Forecast, By Source
- 9.5.5. Market Size and Forecast, By Application
- 9.5.6. Market Size and Forecast, By End User
- 9.5.7. Market Size and Forecast, By Country
- 9.5.8. Brazil Custom Antibody Services Market
  - 9.5.8.1. Market Size and Forecast, By Service
  - 9.5.8.2. Market Size and Forecast, By Type
  - 9.5.8.3. Market Size and Forecast, By Source
  - 9.5.8.4. Market Size and Forecast, By Application
  - 9.5.8.5. Market Size and Forecast, By End User
- 9.5.9. Saudi Arabia Custom Antibody Services Market
  - 9.5.9.1. Market Size and Forecast, By Service
  - 9.5.9.2. Market Size and Forecast, By Type
  - 9.5.9.3. Market Size and Forecast, By Source
  - 9.5.9.4. Market Size and Forecast, By Application
  - 9.5.9.5. Market Size and Forecast, By End User
- 9.5.10. South Africa Custom Antibody Services Market
  - 9.5.10.1. Market Size and Forecast, By Service
  - 9.5.10.2. Market Size and Forecast, By Type
  - 9.5.10.3. Market Size and Forecast, By Source
  - 9.5.10.4. Market Size and Forecast, By Application
  - 9.5.10.5. Market Size and Forecast, By End User
- 9.5.11. Rest of LAMEA Custom Antibody Services Market
  - 9.5.11.1. Market Size and Forecast, By Service
  - 9.5.11.2. Market Size and Forecast, By Type
  - 9.5.11.3. Market Size and Forecast, By Source
  - 9.5.11.4. Market Size and Forecast, By Application
  - 9.5.11.5. Market Size and Forecast, By End User

CHAPTER 10: COMPETITIVE LANDSCAPE

10.1. Introduction
10.2. Top Winning Strategies
10.3. Product Mapping of Top 10 Player
10.4. Competitive Dashboard
10.5. Competitive Heatmap
10.6. Top Player Positioning, 2023

CHAPTER 11: COMPANY PROFILES

11.1. Thermo Fisher Scientific Inc.
- 11.1.1. Company Overview
- 11.1.2. Key Executives
- 11.1.3. Company Snapshot
- 11.1.4. Operating Business Segments
- 11.1.5. Product Portfolio
- 11.1.6. Business Performance
- 11.1.7. Key Strategic Moves and Developments
11.2. Merck KGaA
- 11.2.1. Company Overview
- 11.2.2. Key Executives
- 11.2.3. Company Snapshot
- 11.2.4. Operating Business Segments
- 11.2.5. Product Portfolio
- 11.2.6. Business Performance
- 11.2.7. Key Strategic Moves and Developments
11.3. Agilent Technologies, Inc.
- 11.3.1. Company Overview
- 11.3.2. Key Executives
- 11.3.3. Company Snapshot
- 11.3.4. Operating Business Segments
- 11.3.5. Product Portfolio
- 11.3.6. Business Performance
- 11.3.7. Key Strategic Moves and Developments
11.4. Sino Biological, Inc.
- 11.4.1. Company Overview
- 11.4.2. Key Executives
- 11.4.3. Company Snapshot
- 11.4.4. Operating Business Segments
- 11.4.5. Product Portfolio
- 11.4.6. Business Performance
- 11.4.7. Key Strategic Moves and Developments
11.5. Bio-Rad Laboratories, Inc
- 11.5.1. Company Overview
- 11.5.2. Key Executives
- 11.5.3. Company Snapshot
- 11.5.4. Operating Business Segments
- 11.5.5. Product Portfolio
- 11.5.6. Business Performance
- 11.5.7. Key Strategic Moves and Developments
11.6. Kaneka Eurogentec S.A.
- 11.6.1. Company Overview
- 11.6.2. Key Executives
- 11.6.3. Company Snapshot
- 11.6.4. Operating Business Segments
- 11.6.5. Product Portfolio
- 11.6.6. Business Performance
- 11.6.7. Key Strategic Moves and Developments
11.7. YenZym Antibodies, LLC.
- 11.7.1. Company Overview
- 11.7.2. Key Executives
- 11.7.3. Company Snapshot
- 11.7.4. Operating Business Segments
- 11.7.5. Product Portfolio
- 11.7.6. Business Performance
- 11.7.7. Key Strategic Moves and Developments
11.8. OriGene Technologies, Inc.
- 11.8.1. Company Overview
- 11.8.2. Key Executives
- 11.8.3. Company Snapshot
- 11.8.4. Operating Business Segments
- 11.8.5. Product Portfolio
- 11.8.6. Business Performance
- 11.8.7. Key Strategic Moves and Developments
11.9. Laboratory Corporation of America Holdings.
- 11.9.1. Company Overview
- 11.9.2. Key Executives
- 11.9.3. Company Snapshot
- 11.9.4. Operating Business Segments
- 11.9.5. Product Portfolio
- 11.9.6. Business Performance
- 11.9.7. Key Strategic Moves and Developments
11.10. GenScript
- 11.10.1. Company Overview
- 11.10.2. Key Executives
- 11.10.3. Company Snapshot
- 11.10.4. Operating Business Segments
- 11.10.5. Product Portfolio
- 11.10.6. Business Performance
- 11.10.7. Key Strategic Moves and Developments